MedPath

黑龙江博宇制药有限公司

Ownership
-
Established
2003-07-09
Employees
-
Market Cap
-
Website
www.kelun.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

58

NMPA:58

Drug Approvals

Sodium Chloride Physiological Solution

Product Name
生理氯化钠溶液
Approval Number
国药准字H20253961
Approval Date
Apr 22, 2025
NMPA

Sodium Chloride Physiological Solution

Product Name
生理氯化钠溶液
Approval Number
国药准字H20253960
Approval Date
Apr 22, 2025
NMPA

Sodium Bicarbonate Injection

Product Name
碳酸氢钠注射液
Approval Number
国药准字H20258006
Approval Date
Jan 9, 2025
NMPA

Potassium Chloride Injection

Product Name
氯化钾注射液
Approval Number
国药准字H20249675
Approval Date
Dec 1, 2024
NMPA

Sodium Chloride Injection

Product Name
氯化钠注射液
Approval Number
国药准字H20247228
Approval Date
Sep 29, 2024
NMPA

Sodium Chloride Injection

Product Name
氯化钠注射液
Approval Number
国药准字H20247226
Approval Date
Sep 27, 2024
NMPA

Glucose lnjection

Product Name
葡萄糖注射液
Approval Number
国药准字H20247142
Approval Date
Jun 27, 2024
NMPA

Glucose lnjection

Product Name
葡萄糖注射液
Approval Number
国药准字H20247141
Approval Date
Jun 27, 2024
NMPA

Moxifloxacin Hydrochloride and Sodium Chloride Injection

Product Name
盐酸莫西沙星氯化钠注射液
Approval Number
国药准字H20233218
Approval Date
Feb 28, 2023
NMPA

Sodium Lactate Ringer's Injection

Product Name
乳酸钠林格注射液
Approval Number
国药准字H20083925
Approval Date
Oct 8, 2022
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.